Use in Pregnancy: In animal studies, rivastigmine was not teratogenic. However, the safety of Exelon in human pregnancy has not been established and it should only be given to pregnant women if the potential benefit outweighs the potential risk for the fetus.
Use in Lactation: It is not known if Exelon is excreted into human milk, and patients on Exelon should therefore, not breastfeed.